Pioneering Remote Visit Applications with Comprehensive eCOA Solutions for Phase II/III Trials in China

As the premier provider of Decentralized Clinical Trial (DCT) platform solutions in China, this company specializes in developing a patient-centric intelligent platform for remote clinical trials. By leveraging digital technology, they aim to enhance the accessibility of clinical trials, lessen the burden on patients, boost the quality and efficiency of clinical studies, and minimize drug research and development costs. Their expertise in digital integration supports clinical trials with solutions like ePData, an integrated electronic Clinical Outcome Assessment (eCOA) system, and various tools for scale management, rater training, eDiary, eConsent, and TeleVisit.

The company's commitment to innovation is evident in its comprehensive suite of solutions designed to advance digital technology in Chinese drug research and development. Their integrated eCOA solution stands out for successfully supporting numerous Phase II/III clinical trial projects and pioneering remote visit applications in China. With a dedication to serving patients and contributing positively to society, they consistently work towards empowering and advancing decentralized digitalized clinical trials.